Impact and effectiveness of the quadrivalent human papillomavirus vaccine:A systematic review of 10 years of real-world experience

Autor: Rosybel Drury, Christine Velicer, Stan L. Block, Gonzalo Perez, Alfred J. Saah, Darron R. Brown, Rituparna Das, Géraldine Dominiak-Felden, Barbara J. Kuter, Brianna Lindsay, Mark J. DiNubile, Suzanne M. Garland, Nubia Muñoz, Susanne K. Kjaer
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
Pediatrics
cervical cancer
Drug exposure
Uterine Cervical Neoplasms
Gardasil/Silgard
Disease
Review
Genital warts
Human papillomavirus type 18
Human papillomavirus type 6
0302 clinical medicine
Human Papillomavirus Recombinant Vaccine Quadrivalent
Types 6
11
16
18

Observational study
Medicine
030212 general & internal medicine
Human papillomavirus type 11
CIN
Review Articles
Papillomaviridae
Priority journal
Cervical cancer
Embase
Vaccination
HPV infection
Condyloma acuminatum
Medline
virus diseases
female genital diseases and pregnancy complications
Precancer
Infectious Diseases
Condylomata Acuminata
030220 oncology & carcinogenesis
Female
Uterine cervix cancer
Developed country
genital warts
Human
Microbiology (medical)
medicine.medical_specialty
Immunology
Human Papilloma Virus Vaccine
Histopathology
Papillomavirus infection
Uterine cervix cytology
03 medical and health sciences
Virology
Humans
HPV vaccination
business.industry
Public health
Papillomavirus Infections
medicine.disease
Clinical effectiveness
Systematic review
business
Uterine cervix tumor
Wart virus vaccine
Zdroj: Garland, S M, Kjaer, S K, Muñoz, N, Block, S L, Brown, D R, Dinubile, M J, Lindsay, B R, Kuter, B J, Perez, G, Dominiak-Felden, G, Saah, A J, Drury, R, Das, R & Velicer, C 2016, ' Impact and effectiveness of the quadrivalent human papillomavirus vaccine : A systematic review of 10 years of real-world experience ', Clinical Infectious Diseases, vol. 63, no. 4, pp. 519-527 . https://doi.org/10.1093/cid/ciw354
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
DOI: 10.1093/cid/ciw354
Popis: This systematic review assessed the global impact and effectiveness of quadrivalent human papillomavirus (HPV) vaccination on HPV infection and disease in real-world settings over a decade of use. Substantial reductions in HPV 6/11/16/18 infection, anogenital warts, and cervical lesions have been achieved.
Prophylactic human papillomavirus (HPV) vaccination programs constitute major public health initiatives worldwide. We assessed the global effect of quadrivalent HPV (4vHPV) vaccination on HPV infection and disease. PubMed and Embase were systematically searched for peer-reviewed articles from January 2007 through February 2016 to identify observational studies reporting the impact or effectiveness of 4vHPV vaccination on infection, anogenital warts, and cervical cancer or precancerous lesions. Over the last decade, the impact of HPV vaccination in real-world settings has become increasingly evident, especially among girls vaccinated before HPV exposure in countries with high vaccine uptake. Maximal reductions of approximately 90% for HPV 6/11/16/18 infection, approximately 90% for genital warts, approximately 45% for low-grade cytological cervical abnormalities, and approximately 85% for high-grade histologically proven cervical abnormalities have been reported. The full public health potential of HPV vaccination is not yet realized. HPV-related disease remains a significant source of morbidity and mortality in developing and developed nations, underscoring the need for HPV vaccination programs with high population coverage.
Databáze: OpenAIRE